Of the 110 subjects, 66 were negative in the ONCOblot® Tissue of Origin Cancer Test, indicative of the absence of ENOX2 transcript variants or a level of ENOX2 transcript variants below the level of detection in the test (Table 3). The gene discussed is ENOX2; the disease is cancer.